MCID: EPN001
MIFTS: 40

Ependymoblastoma malady

Categories: Neuronal diseases, Rare diseases, Cancer diseases

Aliases & Classifications for Ependymoblastoma

Aliases & Descriptions for Ependymoblastoma:

Name: Ependymoblastoma 12 56 52 14 69

Characteristics:

Orphanet epidemiological data:

56
ependymoblastoma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

Orphanet: 56  
Rare neurological diseases


External Ids:

Disease Ontology 12 DOID:4794
MeSH 42 D018242
NCIt 47 C4915
SNOMED-CT 64 21589007 253070006
Orphanet 56 ORPHA251880
UMLS via Orphanet 70 C0700367
ICD10 via Orphanet 34 C71.9
UMLS 69 C0700367

Summaries for Ependymoblastoma

MalaCards based summary : Ependymoblastoma is related to pediatric infratentorial ependymoblastoma and adult ependymoblastoma, and has symptoms including headache and vomiting. An important gene associated with Ependymoblastoma is NES (Nestin), and among its related pathways/superpathways are PI3K-Akt signaling pathway and MicroRNAs in cancer. The drugs Fentanyl and Donepezil have been mentioned in the context of this disorder. Affiliated tissues include brain, pons and spinal cord, and related phenotypes are behavior/neurological and cardiovascular system

Related Diseases for Ependymoblastoma

Diseases in the Ependymoblastoma family:

Adult Ependymoblastoma

Diseases related to Ependymoblastoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 119)
id Related Disease Score Top Affiliating Genes
1 pediatric infratentorial ependymoblastoma 11.8
2 adult ependymoblastoma 11.8
3 pediatric cerebral ependymoblastoma 11.8
4 embryonal tumor with multilayered rosettes 10.9
5 pediatric supratentorial ependymoma 10.8
6 onychodystrophy-anonychia 10.2 NES VIM
7 urethral cancer 10.2 MET VIM
8 adult central nervous system primitive neuroectodermal neoplasm 10.2 MET VIM
9 hypothalamic neoplasm 10.2 GFAP NES
10 angiofollicular lymph hyperplasia 10.2 GFAP NES
11 childhood kidney cell carcinoma 10.2 GFAP NES
12 adenofibroma 10.2 GFAP NES
13 hair disease 10.2 NES TP53
14 spleen angiosarcoma 10.2 GFAP VIM
15 superior vena cava syndrome 10.2 GFAP NES
16 myxopapillary ependymoma 10.2 GFAP VIM
17 biliary papillomatosis 10.2 GFAP VIM
18 microinvasive cervical squamous cell carcinoma 10.2 GFAP VIM
19 endometrial stromal sarcoma 10.2 GFAP VIM
20 conjunctival cancer 10.2 TP53 VIM
21 behcet's syndrome arthropathy 10.2 GFAP VIM
22 sternum cancer 10.2 GFAP VIM
23 osteopetrosis, autosomal recessive 8 10.2 GFAP NES
24 aneurysm of sinus of valsalva 10.2 GFAP VIM
25 auricular cancer 10.2 GFAP NES
26 vulvar squamous papilloma 10.2 GFAP VIM
27 hypogonadotropic hypogonadism-retinitis pigmentosa syndrome 10.2 GFAP VIM
28 bronchiolitis obliterans 10.2 GFAP NES
29 dysgerminoma of ovary 10.2 GFAP NES
30 persistent vegetative state 10.2 NES VIM
31 coronary stenosis 10.2 TP53 VIM
32 spastic ataxia 5 10.2 TP53 VIM
33 cauda equina intradural extramedullary astrocytoma 10.2 GFAP VIM
34 pediculus humanus corporis infestation 10.2 GFAP NES
35 ovarian epithelial cancer 10.2 NES VIM
36 ovarian insufficiency due to fsh resistance 10.2 MET VIM
37 glomangioma 10.2 TP53 VIM
38 skin glomus tumor 10.2 GFAP VIM
39 ossifying fibromyxoid tumor 10.2 TP53 VIM
40 growth retardation hydrocephaly lung hypoplasia 10.2 TP53 VIM
41 liver fibrosarcoma 10.2 GFAP TP53
42 cervical adenoid cystic carcinoma 10.2 GFAP TP53
43 house allergic alveolitis 10.2 MET TP53
44 bronchitis 10.2 GFAP TP53
45 bile duct clear cell adenocarcinoma 10.2 GFAP TP53
46 cervical benign neoplasm 10.1 GFAP TP53
47 clear cell meningioma 10.1 GFAP TP53
48 porokeratosis 10.1 GFAP TP53
49 enchondromatosis dwarfism deafness 10.1 TP53 VIM
50 granulomatous myositis 10.1 NES TP53

Graphical network of the top 20 diseases related to Ependymoblastoma:



Diseases related to Ependymoblastoma

Symptoms & Phenotypes for Ependymoblastoma

UMLS symptoms related to Ependymoblastoma:


headache, vomiting

MGI Mouse Phenotypes related to Ependymoblastoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.85 GFAP LIN28A MET NGF TP53 VIM
2 cardiovascular system MP:0005385 9.8 GFAP LIN28A MET NGF TP53 VIM
3 muscle MP:0005369 9.73 TP53 VIM GFAP LIN28A MET NGF
4 nervous system MP:0003631 9.63 GFAP LIN28A MET NGF TP53 VIM
5 normal MP:0002873 9.35 NGF TP53 GFAP LIN28A MET
6 vision/eye MP:0005391 9.02 GFAP MET NGF TP53 VIM

Drugs & Therapeutics for Ependymoblastoma

Drugs for Ependymoblastoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 175)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
3
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
4
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
5
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
6
Ondansetron Approved Phase 3 99614-02-5 4595
7
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
8
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
9
Cyproheptadine Approved Phase 3 129-03-3 2913
10
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
11 Dermatologic Agents Phase 3,Phase 2,Phase 1
12 Adjuvants, Anesthesia Phase 3
13 Analgesics Phase 3,Phase 2,Phase 1
14 Analgesics, Opioid Phase 3
15 Anesthetics Phase 3
16 Anesthetics, General Phase 3
17 Anesthetics, Intravenous Phase 3
18 Central Nervous System Depressants Phase 3,Phase 2
19 Liver Extracts Phase 3,Phase 1,Phase 2
20 Narcotics Phase 3
21 pancreatic polypeptide Phase 3,Phase 1
22 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
23 Cholinergic Agents Phase 3,Phase 2
24 Cholinesterase Inhibitors Phase 3,Phase 2
25 Neurotransmitter Agents Phase 3,Phase 2
26 Nootropic Agents Phase 3,Phase 2
27 Gastrointestinal Agents Phase 3,Phase 1
28 Antiemetics Phase 3,Phase 1
29 Autonomic Agents Phase 3,Phase 1
30 BB 1101 Phase 3,Phase 2,Phase 1
31 Dexamethasone 21-phosphate Phase 3,Phase 2,Phase 1
32 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
33 Emetics Phase 3
34 Central Nervous System Stimulants Phase 3
35 Dexmethylphenidate Hydrochloride Phase 3
36 Dopamine Agents Phase 3
37 Dopamine Uptake Inhibitors Phase 3
38 Neurotransmitter Uptake Inhibitors Phase 3
39 Anti-Allergic Agents Phase 3
40 Antipruritics Phase 3
41 Histamine Antagonists Phase 3
42 Histamine H1 Antagonists Phase 3
43
Histamine Phosphate Phase 3 51-74-1 65513
44
Serotonin Phase 3 50-67-9 5202
45 Serotonin Agents Phase 3
46 Serotonin Antagonists Phase 3
47 Cola Nutraceutical Phase 3,Phase 1
48
Bevacizumab Approved, Investigational Phase 2 216974-75-3
49
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
50
Etoposide Approved Phase 2,Phase 1 33419-42-0 36462

Interventional clinical trials:

(show top 50) (show all 53)
id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3
3 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Active, not recruiting NCT01346267 Phase 3
4 Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors Terminated NCT00031798 Phase 3
5 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
6 Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma Completed NCT00883688 Phase 2
7 Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma Completed NCT00006258 Phase 2
8 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2
9 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2
10 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Completed NCT00014573 Phase 2
11 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors Completed NCT00003478 Phase 1, Phase 2
12 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers Completed NCT00002752 Phase 1, Phase 2
13 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Recruiting NCT00983398 Phase 1, Phase 2
14 Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors Recruiting NCT02684071 Phase 2
15 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Recruiting NCT01977677 Phase 1, Phase 2
16 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
17 Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Active, not recruiting NCT00939770 Phase 1, Phase 2
18 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2
19 Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors Withdrawn NCT00005083 Phase 2
20 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1
21 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Gluco Completed NCT01082926 Phase 1
22 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1
23 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1
24 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Completed NCT00030498 Phase 1
25 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1
26 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1
27 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1
28 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1
29 CC-5013 in Treating Patients With Recurrent Glioma Completed NCT00036894 Phase 1
30 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1
31 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
32 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1
33 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1
34 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1
35 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
36 Carmustine in Treating Patients With Recurrent Malignant Glioma Completed NCT00004028 Phase 1
37 Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer Completed NCT00003022 Phase 1
38 Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas Completed NCT00002753 Phase 1
39 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1
40 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1
41 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1
42 Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Terminated NCT00003567 Phase 1
43 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial Completed NCT00890435
44 Study of Blood and Cheek Cell Samples From Patients With Glioma Completed NCT01009307
45 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors Completed NCT00967200
46 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914
47 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors Completed NCT00499798
48 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders Completed NCT00255671
49 Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma Completed NCT00005082
50 Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Terminated NCT02967380

Search NIH Clinical Center for Ependymoblastoma

Genetic Tests for Ependymoblastoma

Anatomical Context for Ependymoblastoma

MalaCards organs/tissues related to Ependymoblastoma:

39
Brain, Pons, Spinal Cord

Publications for Ependymoblastoma

Articles related to Ependymoblastoma:

(show top 50) (show all 58)
id Title Authors Year
1
Sacrococcygeal ependymoblastoma. ( 26493054 )
2015
2
Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12A years survival after gross total resection followed by chemotherapy. ( 26251773 )
2015
3
Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. ( 25916887 )
2015
4
Ependymoblastoma of the brainstem: MRI findings and differential diagnosis. ( 24464920 )
2014
5
MRI characteristics of ependymoblastoma: results from 22 centrally reviewed cases. ( 24948504 )
2014
6
Ependymoblastoma with cystic change in a child. ( 24724717 )
2014
7
A case report of an ependymoblastoma in the rectovaginal space and a review of the literature. ( 24511018 )
2014
8
MET T992I mutation in a case of ependymoblastoma/embryonal tumour with multilayered rosettes. ( 25194039 )
2014
9
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. ( 24337497 )
2013
10
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. ( 21308398 )
2011
11
Ependymoblastoma in an adult: a diagnostic challenge on cytology. ( 22674109 )
2011
12
Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*. ( 19120373 )
2010
13
Ependymoblastoma in a Japanese Black heifer. ( 19887749 )
2009
14
Congenital ependymoblastoma arising in the sacrococcygeal soft tissue: a case study. ( 18402386 )
2008
15
Divergent ependymal tumor (ependymoblastoma/anaplastic ependymoma) of the posterior fossa: an uncommon case observed in a child. ( 18827270 )
2008
16
Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor. ( 17453820 )
2007
17
In vitro human ependymoblastoma cells differentiate after exposure to nerve growth factor. ( 15906158 )
2004
18
Ependymoblastoma: MR presentation. A case report and review of the literature. ( 7491192 )
1995
19
Ependymoblastoma: a clinical review. ( 8570066 )
1995
20
Ependymoblastoma in an HIV-positive hemophilic girl. ( 8084312 )
1994
21
Tentorial traversal by ependymoblastoma. ( 1899507 )
1991
22
Limits of tumour treatment follow up by surface coil 31P magnetic resonance spectroscopy. The case of sarcosinamide-CNU treated ependymoblastoma. ( 2484278 )
1989
23
Ependymoblastoma: a histological, immunohistological and ultrastructural study of five cases. ( 3286469 )
1988
24
Congenital ependymoblastoma presenting as a sacrococcygeal mass in a newborn: an immunohistochemical, light and electron microscopic study. ( 3308267 )
1987
25
The expression and detection of MHC class I antigens on murine neuroblastoma and ependymoblastoma lines. ( 3492512 )
1987
26
The ultrastructure of the ependymoblastoma. ( 3776467 )
1986
27
Primary intracranial ependymoblastoma presenting as spinal cord compression due to metastasis. ( 3829033 )
1986
28
Primary leptomeningeal ependymoblastoma. Case report. ( 3701447 )
1986
29
Ependymoblastoma. A reappraisal of a rare embryonal tumor. ( 3978547 )
1985
30
Ependymoblastoma associated with prenatal exposure to diphenylhydantoin and methylphenobarbitone. ( 3978571 )
1985
31
Ependymoblastoma in a dairy calf. ( 6485211 )
1984
32
The murine ependymoblastoma: growth pattern and survival in C57Bl/6J mice. ( 6861007 )
1983
33
Congenital ependymoblastoma. ( 7188822 )
1980
34
Synergistic effect of combined hyperthermia and a nitrosourea in treatment of a murine ependymoblastoma. ( 7388821 )
1980
35
Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. ( 7471107 )
1980
36
Isolation of plasma membranes from murine ependymoblastoma and subcellular distribution of amphotericin B in this tumor. ( 851531 )
1977
37
Nonspecific inhibition of tumor growth in the central nervous system: observations of intracerebral ependymoblastoma in mice with chronic Toxoplasma infection. ( 894752 )
1977
38
Transplantation resistance to mouse ependymoblastoma following immunization with dehistonized syngeneic tumor chromatin. ( 1268848 )
1976
39
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma. ( 975049 )
1976
40
Increased survival of mouse ependymoblastoma hosts previously treated with dehistonized tumor chromatin. ( 1153860 )
1975
41
An ependymoblastoma of the pons. ( 1159567 )
1975
42
Recent experience with intrathecal radiogold for medulloblastoma and ependymoblastoma: a progress report. ( 4479529 )
1974
43
A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. ( 4447935 )
1974
44
The fine structure of ependymoblastoma. ( 4685709 )
1973
45
The uptake of hydrocortisone in mouse brain and ependymoblastoma. ( 5008732 )
1972
46
Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. ( 5037043 )
1972
47
Shortcomings of 99m Tc-pertechnetate as a tracer for brain tumor detection as shown by well counting of human brain tumors and a mouse ependymoblastoma. ( 4336247 )
1972
48
Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma. ( 4537157 )
1972
49
Morphology of virus-like particles persisting in murine ependymoblastoma in vitro. ( 4323350 )
1970
50
The definition of the ependymoblastoma. ( 5426275 )
1970

Variations for Ependymoblastoma

Expression for Ependymoblastoma

Search GEO for disease gene expression data for Ependymoblastoma.

Pathways for Ependymoblastoma

GO Terms for Ependymoblastoma

Cellular components related to Ependymoblastoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 intermediate filament cytoskeleton GO:0045111 8.96 GFAP NES
2 intermediate filament GO:0005882 8.8 GFAP NES VIM

Biological processes related to Ependymoblastoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.13 NGF TP53 VIM
2 phosphatidylinositol-mediated signaling GO:0048015 8.8 MET NGF TP53

Molecular functions related to Ependymoblastoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein phosphatase binding GO:0019903 8.62 MET TP53

Sources for Ependymoblastoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....